Renal cell carcinoma

Expression of microRNA-210 in tissue and serum of renal carcinoma patients and its effect on renal carcinoma cell proliferation, apoptosis, and invasion

T. Y. Liu, Zhang, H., Du, S. M., Li, J., Wen, X. H., Liu, T. Y., Zhang, H., Du, S. M., Li, J., and Wen, X. H., Expression of microRNA-210 in tissue and serum of renal carcinoma patients and its effect on renal carcinoma cell proliferation, apoptosis, and invasion, vol. 15, p. -, 2016.

This study investigated the expression of microRNA-210 (miR-210) in tissue and serum of renal carcinoma patients and its effect on renal carcinoma cell proliferation, apoptosis, and invasion. Thirty-two renal carcinoma patients in our hospital were selected as the study group and 32 people receiving a physical examination were selected as the control group. miR-210 expression in the serum of renal carcinoma patients and in healthy subjects was quantified by real-time polymerase chain reaction.

Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study

B. - L. Shen, Qu, Q. - S., Miao, S. - Z., and Zhang, Y. - X., Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study, vol. 14, pp. 11119-11125, 2015.

We conducted this case-control study to assess the role of the VEGF -2578C/A, +1612G/A, +936C/T and -634G/C gene polymorphisms in the development of renal cell carcinoma (RCC). A hospital-based case-control study was conducted in a 360 consecutive primary RCC patients and 360 age and gender-matched controls during January 2010 and January 2014. The polymerase chain reaction-restriction fragment length polymorphism was used for VEGF -2578C/A, +1612G/A, +936C/T and -634G/C genotyping.

Subscribe to Renal cell carcinoma